AcelRx Pharmaceuticals
ACRX
#7308
Rank
$11.47 M
Marketcap
$1.05
Share price
-3.67%
Change (1 day)
-76.14%
Change (1 year)

P/E ratio for AcelRx Pharmaceuticals (ACRX)

P/E ratio as of June 2023 (TTM): 0.1677

According to AcelRx Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0.167732. At the end of 2021 the company had a P/E ratio of -0.0966.

P/E ratio history for AcelRx Pharmaceuticals from 2011 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-0.0966-25.22%
2020-0.1292-95.9%
2019-3.1511.79%
2018-2.82
2013-17.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-2.79-1,761.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.94-1,258.63%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.